Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression
NCT01471821
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
250
Enrollment
OTHER
Sponsor class
Conditions
HIV Infection
Interventions
DRUG:
antiretroviral treatment
Sponsor
Juan A. Arnaiz